等待开盘 01-12 09:30:00 美东时间
+1.010
+0.76%
今日重点评级关注:Needham:维持Cartesian Therapeutics"买入"评级,目标价从40美元升至42美元;Piper Sandler:维持Acrivon Therapeutics"超配"评级,目标价从6美元升至8美元
今天 14:09
Barclays analyst Benjamin Budish maintains KKR (NYSE:KKR) with a Overweight and lowers the price target from $169 to $159.
01-09 22:58
OneStream receives an offer from Hg Capital for $24 per share. Analysts from Needham, Rosenblatt and BTIG provide insights.
01-08 21:31
KKR, a leading global investment firm, today announced that it is making an additional $1.5 billion equity commitment to Global Technical Realty ("GTR"), a multi-billion dollar European built-to-suit data center
01-07 20:04
https://www.bloomberg.com/news/articles/2026-01-06/kkr-agrees-to-buy-sports-investor-arctos-at-1-billion-valuation
01-07 06:52
KKR's 2026 Outlook finds value beyond the S&P 500. Explore investment strategies in Asia, biotech, and critical infrastructure.
2025-12-24 16:04
Blockchain technology is solving a problem that has existed in finance for centuries: how do you make expensive, illiquid assets accessible to everyday investors? The answer involves converting traditional assets into digital tokens that can be bought, sold, and traded like stocks.
2025-12-22 22:46
https://www.bloomberg.com/news/articles/2025-12-19/kkr-is-said-to-emerge-as-frontrunner-to-acquire-japan-s-taiyo
2025-12-19 17:12
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
Barclays analyst Benjamin Budish maintains KKR (NYSE:KKR) with a Overweight and raises the price target from $154 to $169.
2025-12-13 04:19